Literature DB >> 26586659

Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)-Induced Pulmonary Hypertension.

Roger A Johns1, Eiki Takimoto1, Lucas W Meuchel1, Esra Elsaigh1, Ailan Zhang1, Nicola M Heller1, Gregg L Semenza1, Kazuyo Yamaji-Kegan2.   

Abstract

OBJECTIVE: Pulmonary hypertension (PH) is characterized by progressive elevation of pulmonary vascular resistance, right ventricular failure, and ultimately death. We have shown that in rodents, hypoxia-induced mitogenic factor (HIMF; also known as FIZZ1 or resistin-like molecule-β) causes PH by initiating lung vascular inflammation. We hypothesized that hypoxia-inducible factor-1 (HIF-1) is a critical downstream signal mediator of HIMF during PH development. APPROACH AND
RESULTS: In this study, we compared the degree of HIMF-induced pulmonary vascular remodeling and PH development in wild-type (HIF-1α(+/+)) and HIF-1α heterozygous null (HIF-1α(+/-)) mice. HIMF-induced PH was significantly diminished in HIF-1α(+/-) mice and was accompanied by a dysregulated vascular endothelial growth factor-A-vascular endothelial growth factor receptor 2 pathway. HIF-1α was critical for bone marrow-derived cell migration and vascular tube formation in response to HIMF. Furthermore, HIMF and its human homolog, resistin-like molecule-β, significantly increased interleukin (IL)-6 in macrophages and lung resident cells through a mechanism dependent on HIF-1α and, at least to some extent, on nuclear factor κB.
CONCLUSIONS: Our results suggest that HIF-1α is a critical downstream transcription factor for HIMF-induced pulmonary vascular remodeling and PH development. Importantly, both HIMF and human resistin-like molecule-β significantly increased IL-6 in lung resident cells and increased perivascular accumulation of IL-6-expressing macrophages in the lungs of mice. These data suggest that HIMF can induce HIF-1, vascular endothelial growth factor-A, and interleukin-6, which are critical mediators of both hypoxic inflammation and PH pathophysiology.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  hypertension; hypoxia-inducible factor 1; interleukins; macrophages; pulmonary; resistin-like molecule

Mesh:

Substances:

Year:  2015        PMID: 26586659      PMCID: PMC5518796          DOI: 10.1161/ATVBAHA.115.306710

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  60 in total

1.  Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension.

Authors:  Eleni Vergadi; Mun Seog Chang; Changjin Lee; Olin D Liang; Xianlan Liu; Angeles Fernandez-Gonzalez; S Alex Mitsialis; Stella Kourembanas
Journal:  Circulation       Date:  2011-04-25       Impact factor: 29.690

2.  Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes.

Authors:  Sahmin Lee; Hyun-Chae Lee; Yoo-Wook Kwon; Sang Eun Lee; Youngjin Cho; Joonoh Kim; Soobeom Lee; Ju-Young Kim; Jaewon Lee; Han-Mo Yang; Inhee Mook-Jung; Ky-Youb Nam; Junho Chung; Mitchell A Lazar; Hyo-Soo Kim
Journal:  Cell Metab       Date:  2014-03-04       Impact factor: 27.287

3.  Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension.

Authors:  Takahiro Hashimoto-Kataoka; Naoki Hosen; Takashi Sonobe; Yoh Arita; Taku Yasui; Takeshi Masaki; Masato Minami; Tadakatsu Inagaki; Shigeru Miyagawa; Yoshiki Sawa; Masaaki Murakami; Atsushi Kumanogoh; Keiko Yamauchi-Takihara; Meinoshin Okumura; Tadamitsu Kishimoto; Issei Komuro; Mikiyasu Shirai; Yasushi Sakata; Yoshikazu Nakaoka
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-04       Impact factor: 11.205

4.  FIZZ2/RELM-β induction and role in pulmonary fibrosis.

Authors:  Tianju Liu; Hyun Ah Baek; Hongfeng Yu; Ho Jin Lee; Byung-Hyun Park; Matthew Ullenbruch; Jianhua Liu; Taku Nakashima; Yoon Young Choi; Gary D Wu; Myoung Ja Chung; Sem H Phan
Journal:  J Immunol       Date:  2011-05-20       Impact factor: 5.422

5.  Bone marrow-derived cells serve as proangiogenic macrophages but not endothelial cells in wound healing.

Authors:  Yuji Okuno; Ayako Nakamura-Ishizu; Kazuo Kishi; Toshio Suda; Yoshiaki Kubota
Journal:  Blood       Date:  2011-03-16       Impact factor: 22.113

6.  Digoxin inhibits development of hypoxic pulmonary hypertension in mice.

Authors:  Edsel M Abud; Julie Maylor; Clark Undem; Arjun Punjabi; Ari L Zaiman; Allen C Myers; J T Sylvester; Gregg L Semenza; Larissa A Shimoda
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-09       Impact factor: 11.205

7.  Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis.

Authors:  R M Tuder; M Chacon; L Alger; J Wang; L Taraseviciene-Stewart; Y Kasahara; C D Cool; A E Bishop; M Geraci; G L Semenza; M Yacoub; J M Polak; N F Voelkel
Journal:  J Pathol       Date:  2001-10       Impact factor: 7.996

8.  FIZZ1/RELMalpha, a novel hypoxia-induced mitogenic factor in lung with vasoconstrictive and angiogenic properties.

Authors:  Xingwu Teng; Dechun Li; Hunter C Champion; Roger A Johns
Journal:  Circ Res       Date:  2003-04-24       Impact factor: 17.367

9.  Resistin-like molecule-beta in scleroderma-associated pulmonary hypertension.

Authors:  Daniel J Angelini; Qingning Su; Kazuyo Yamaji-Kegan; Chunling Fan; Xingwu Teng; Paul M Hassoun; Stephen C Yang; Hunter C Champion; Rubin M Tuder; Roger A Johns
Journal:  Am J Respir Cell Mol Biol       Date:  2009-02-27       Impact factor: 6.914

10.  Resistin-like molecule-β (RELM-β) targets airways fibroblasts to effect remodelling in asthma: from mouse to man.

Authors:  C L Fang; L J Yin; S Sharma; S Kierstein; H F Wu; G Eid; A Haczku; C J Corrigan; S Ying
Journal:  Clin Exp Allergy       Date:  2015-05       Impact factor: 5.018

View more
  20 in total

1.  A Time- and Compartment-Specific Activation of Lung Macrophages in Hypoxic Pulmonary Hypertension.

Authors:  Steven C Pugliese; Sushil Kumar; William J Janssen; Brian B Graham; Maria G Frid; Suzette R Riddle; Karim C El Kasmi; Kurt R Stenmark
Journal:  J Immunol       Date:  2017-05-12       Impact factor: 5.422

Review 2.  Hypoxia-inducible factor signaling in pulmonary hypertension.

Authors:  Soni Savai Pullamsetti; Argen Mamazhakypov; Norbert Weissmann; Werner Seeger; Rajkumar Savai
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

3.  RELMα Licenses Macrophages for Damage-Associated Molecular Pattern Activation to Instigate Pulmonary Vascular Remodeling.

Authors:  Qing Lin; Chunling Fan; John T Skinner; Elizabeth N Hunter; Andrew A Macdonald; Peter B Illei; Kazuyo Yamaji-Kegan; Roger A Johns
Journal:  J Immunol       Date:  2019-10-14       Impact factor: 5.422

4.  HIMF (Hypoxia-Induced Mitogenic Factor) Signaling Mediates the HMGB1 (High Mobility Group Box 1)-Dependent Endothelial and Smooth Muscle Cell Crosstalk in Pulmonary Hypertension.

Authors:  Qing Lin; Chunling Fan; Jose Gomez-Arroyo; Katrien Van Raemdonck; Lucas W Meuchel; John T Skinner; Allen D Everett; Xia Fang; Andrew A Macdonald; Kazuyo Yamaji-Kegan; Roger A Johns
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-10-10       Impact factor: 8.311

5.  Reporting Sex and Sex Differences in Preclinical Studies.

Authors:  Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

Review 6.  Resistin family proteins in pulmonary diseases.

Authors:  Qing Lin; Roger A Johns
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-06-17       Impact factor: 5.464

Review 7.  Endothelial cells in the pathogenesis of pulmonary arterial hypertension.

Authors:  Colin E Evans; Nicholas D Cober; Zhiyu Dai; Duncan J Stewart; You-Yang Zhao
Journal:  Eur Respir J       Date:  2021-09-02       Impact factor: 33.795

8.  The inflammatory role of dysregulated IRS2 in pulmonary vascular remodeling under hypoxic conditions.

Authors:  Mayumi Nakahara; Homare Ito; John T Skinner; Qing Lin; Rasa Tamosiuniene; Mark R Nicolls; Achsah D Keegan; Roger A Johns; Kazuyo Yamaji-Kegan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-06-30       Impact factor: 6.011

9.  Synthesis and Biological Evaluation of a New Nitroimidazole-99mTc-Complex for Imaging of Hypoxia in Mice Model.

Authors:  Qing Zhang; Qing Zhang; Yanxing Guan; Shaozheng Liu; Qingjie Chen; Xiangmin Li
Journal:  Med Sci Monit       Date:  2016-10-18

Review 10.  Novel Therapeutic Targets for Hypoxia-Related Cardiovascular Diseases: The Role of HIF-1.

Authors:  Minxuan Liu; Gina Galli; Yilin Wang; Qiru Fan; Zhenzhong Wang; Xin Wang; Wei Xiao
Journal:  Front Physiol       Date:  2020-07-15       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.